Nerviens Development: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Nerviens Development
Largest movements
- Cash +€376,813
up €376,813 (+1846.0%), from €20,413 to €397,226
mainly Debts after one year (+€1.4m) and Net result for the year (+€24,354)
- Debts after one year +€1.4m
up €1.4m (+20.6%), from €6.9m to €8.3m
- Short-term financial debts -€900,000
down €900,000 (-5.9%), from €15.4m to €14.5m
- Financial charges -€608,445
down €608,445 (-32.1%), from €1.9m to €1.3m
- Gross operating margin -€238,972
down €238,972 (-15.4%), from €1.5m to €1.3m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €22,494,167 | €23,055,074 | +€560,907 | +2.5% |
| Current assets | 29/58 | €22,494,167 | €23,055,074 | +€560,907 | +2.5% |
| Stocks and contracts in progress | 3 | €22,468,664 | €22,652,966 | +€184,302 | +0.8% |
| Stocks | 30/36 | €22,468,664 | €22,652,966 | +€184,302 | +0.8% |
| Amounts receivable within one year | 40/41 | €1,397 | €0 | -€1,397 | -100.0% |
| Trade receivables | 40 | €1,397 | €0 | -€1,397 | -100.0% |
| Cash at bank and in hand | 54/58 | €20,413 | €397,226 | +€376,813 | +1846.0% |
| Deferred charges and accrued income | 490/1 | €3,693 | €4,882 | +€1,189 | +32.2% |
| Total equity and liabilities | 10/49 | €22,494,167 | €23,055,074 | +€560,907 | +2.5% |
| Equity | 10/15 | -€294,917 | -€270,563 | +€24,354 | +8.3% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€344,917 | -€320,563 | +€24,354 | +7.1% |
| Amounts payable | 17/49 | €22,789,084 | €23,325,637 | +€536,553 | +2.4% |
| Amounts payable after more than one year | 17 | €6,879,605 | €8,295,521 | +€1.4m | +20.6% |
| Financial debts | 170/4 | €6,879,605 | €8,295,521 | +€1.4m | +20.6% |
| Amounts payable within one year | 42/48 | €15,383,819 | €14,482,736 | -€901,083 | -5.9% |
| Financial debts | 43 | €15,375,000 | €14,475,000 | -€900,000 | -5.9% |
| Credit institutions | 430/8 | €15,375,000 | €14,475,000 | -€900,000 | -5.9% |
| Trade debts | 44 | €8,819 | €7,736 | -€1,083 | -12.3% |
| Suppliers | 440/4 | €8,819 | €7,736 | -€1,083 | -12.3% |
| Accrued charges and deferred income | 492/3 | €525,660 | €547,380 | +€21,720 | +4.1% |
| Other operating charges | 640/8 | €1,878 | €2,082 | +€203 | +10.8% |
| Gross operating margin | 9900 | €1,549,997 | €1,311,025 | -€238,972 | -15.4% |
| Operating profit (loss) | 9901 | €1,548,118 | €1,308,944 | -€239,175 | -15.4% |
| Financial charges | 65/66B | €1,893,035 | €1,284,590 | -€608,445 | -32.1% |
| Recurring financial charges | 65 | €1,893,035 | €1,284,590 | -€608,445 | -32.1% |
| Profit (loss) for the period before taxes | 9903 | -€344,917 | €24,354 | +€369,270 | |
| Profit (loss) for the period | 9904 | -€344,917 | €24,354 | +€369,270 | |
| Profit (loss) for the period to be appropriated | 9905 | -€344,917 | €24,354 | +€369,270 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.